Emily Heikamp, MD, PhD
Attending, Cancer and Blood Disorders Center
Instructor, Harvard Medical School
Image
Emily Heikamp, MD, PhD
Attending, Cancer and Blood Disorders Center
Instructor, Harvard Medical School
Medical Services
Education
Undergraduate School
Duke University
2005
Durham
NC
Graduate School
Oxford University
2008
Oxford
United Kingdom
Medical School
Johns Hopkins School of Medicine
2015
Baltimore
MD
Internship
Internship
Baylor College of Medicine
2016
Houston
TX
Residency
Pediatrics
Baylor College of Medicine
2018
Houston
TX
Fellowship
Pediatric Hematology, Oncology, and Stem Cell Transplant
Dana-Farber Cancer Institute
2021
Boston
MA
Publications
Epigenetic Therapies. View Abstract
Revumenib Revises the Treatment Landscape for KMT2A-r Leukemia. View Abstract
NUP98 fusion proteins and KMT2A-MENIN antagonize PRC1.1 to drive gene expression in AML. View Abstract
Cutting Edge: mTORC2 Regulates CD8+ Effector and Memory T Cell Differentiation through Serum and Glucocorticoid Kinase 1. View Abstract
Cutting Edge: mTORC2 Regulates CD8+ Effector and Memory T Cell Differentiation through Serum and Glucocorticoid Kinase 1. View Abstract
Calculated decisions: Step-by-Step Approach to Febrile Infants. View Abstract
The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML. View Abstract
Large DNA Methylation Nadirs Anchor Chromatin Loops Maintaining Hematopoietic Stem Cell Identity. View Abstract
50 Years Ago in TheJournalofPediatrics: The Need for Chemotherapy after Prolonged Complete Remission in Acute Leukemia of Childhood. View Abstract
Calculated Decisions: Step-by-Step Approach to Febrile Infants View Abstract
Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia. View Abstract
50 Years Ago in The Journal Of Pediatrics: Treatment of Ewing Sarcoma with Concurrent Radiotherapy and Chemotherapy. View Abstract
Revisiting the use of probiotics in premature infants for the prevention of NEC. View Abstract
50 Years Ago in The Journal of Pediatrics: Familial Granulocytopenia and Associated Immunoglobulin Abnormality: Report of 3 Cases in Young Brothers. View Abstract
50 Years Ago in The Journal of Pediatrics: Prevention and Management of Acute Hyperuricemia in Childhood Leukemia. View Abstract
50 Years Ago in The Journal of Pediatrics: Thymic Dysplasia ("Swiss Agammaglobulinemia"). I. Graft Versus Host Reaction following Bone-Marrow Transfusion. View Abstract
50 Years Ago in The Journal of Pediatrics: Sequential Therapy of Acute Leukemia in Childhood. View Abstract
50 Years Ago in The Journal of Pediatrics: Diencephalic Syndromes of Infancy: Report of 3 Children with Emaciation Syndrome and Disproportionately Large Hands and Feet. View Abstract
50 Years Ago in The Journal of Pediatrics: Wiskott-Aldrich Syndrome: Clinical, Immunologic, and Pathologic Observations. View Abstract
50 Years Ago in The Journal of Pediatrics: Adrenocortical Neoplasms with Hemihypertrophy, Brain Tumors, and Other Disorders. View Abstract
The AGC kinase SGK1 regulates TH1 and TH2 differentiation downstream of the mTORC2 complex. View Abstract
A modified model of T-cell differentiation based on mTOR activity and metabolism. View Abstract
Sensing the immune microenvironment to coordinate T cell metabolism, differentiation & function. View Abstract
Regulation of immune responses by mTOR. View Abstract
The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. View Abstract
New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes. View Abstract
Multiple, conserved cryptic recombination signals in VH gene segments: detection of cleavage products only in pro B cells. View Abstract
Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo. View Abstract
Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. View Abstract